1 | antiretroviral | 3,535 |
2 | antiplatelet | 2,737 |
3 | anticoagulant | 1,514 |
4 | thrombolytic | 1,335 |
5 | antithrombotic | 1,050 |
6 | photodynamic | 524 |
7 | anti-tnf | 413 |
8 | electroconvulsive | 265 |
9 | anti-vegf | 244 |
10 | anti-platelet | 200 |
11 | anti-egfr | 181 |
12 | anti-hcv | 156 |
13 | anti-her2 | 122 |
14 | anti-ige | 116 |
15 | anti-retroviral | 83 |
16 | anti-tnf-α | 81 |
17 | anti-tnfα | 75 |
18 | anti-tnf-alpha | 58 |
19 | androgen-deprivation | 57 |
20 | cognitive-behavior | 55 |
21 | urate-lowering | 55 |
22 | interferon-based | 49 |
23 | cognitive-behaviour | 44 |
24 | nicotine-replacement | 43 |
25 | bone-targeted | 37 |
26 | waon | 37 |
27 | hormone-replacement | 31 |
28 | dual-antiplatelet | 30 |
29 | anti-tnfalpha | 29 |
30 | anti-ctla-4 | 27 |
31 | morita | 27 |
32 | egfr-targeted | 26 |
33 | anti-diabetes | 24 |
34 | anti-leukotriene | 24 |
35 | vegf-targeted | 24 |
36 | electrophysical | 23 |
37 | her2-targeted | 22 |
38 | anti-tuberculous | 20 |
39 | chemoendocrine | 20 |
40 | dance/movement | 19 |
41 | pah-specific | 19 |
42 | anti-aβ | 18 |
43 | antilipid | 18 |
44 | estrogen-progestogen | 18 |
45 | mud-bath | 18 |
46 | tsh-suppressive | 18 |
47 | anticytokine | 17 |
48 | anti-coagulant | 16 |
49 | renal-replacement | 16 |
50 | adpri | 14 |
51 | aliskiren-based | 14 |
52 | chemohormonal | 14 |
53 | chemo-endocrine | 13 |
54 | anti-cytokine | 12 |
55 | anti-hormonal | 12 |
56 | anti-il-12/23 | 12 |
57 | anti-il-13 | 12 |
58 | glp-1-based | 12 |
59 | ifn-based | 12 |
60 | tnf-blocking | 12 |
61 | anti-pd-1 | 11 |
62 | hdl-raising | 11 |
63 | ramipril-based | 11 |
64 | medicamental | 10 |
65 | anti-filarial | 9 |
66 | anticholesterol | 9 |
67 | bone-modifying | 9 |
68 | levodopa-sparing | 9 |
69 | thionamide | 9 |
70 | antihypotensive | 8 |
71 | antileukotriene | 8 |
72 | novottf | 8 |
73 | pet-adapted | 8 |
74 | pre-antiretroviral | 8 |
75 | animal-assisted | 7 |
76 | anti-leukaemic | 7 |
77 | bioresonance | 7 |
78 | egfr-targeting | 7 |
79 | ph-specific | 7 |
80 | vitalstim | 7 |
81 | yin-nourishing | 7 |
82 | anti-her-2 | 6 |
83 | anti-il-1 | 6 |
84 | aspirin-oac | 6 |
85 | cytokine-based | 6 |
86 | her2-directed | 6 |
87 | ifn-α-based | 6 |
88 | pbto2-based | 6 |
89 | tuberculostatic | 6 |
90 | anti-proteus | 5 |
91 | beta-lactam-based | 5 |
92 | chin-cup | 5 |
93 | coinitiation | 5 |
94 | cpp-targeted | 5 |
95 | electro-convulsive | 5 |
96 | molecularly-targeted | 5 |
97 | music-movement | 5 |
98 | nonsensitizer | 5 |
99 | probucol-colestipol | 5 |
100 | radiopeptide | 5 |
101 | sofosbuvir-based | 5 |
102 | third-tier | 5 |
103 | acupoint-sticking | 4 |
104 | anti-failure | 4 |
105 | anti-hcmv | 4 |
106 | anti-t-cell | 4 |
107 | antiplatelet/no | 4 |
108 | bian-stone | 4 |
109 | cryo-tcm | 4 |
110 | cryoultrasound | 4 |
111 | enzyme-replacement | 4 |
112 | eryc | 4 |
113 | estrogen-replacement | 4 |
114 | her-2-directed | 4 |
115 | hypnosis/relaxation | 4 |
116 | icp/cpp-based | 4 |
117 | paricalcitol-centred | 4 |
118 | preload-reduction | 4 |
119 | prn-pde5i | 4 |
120 | rdtb | 4 |
121 | self-manual | 4 |
122 | sox+bv | 4 |
123 | statin/fibrate | 4 |
124 | su-jok | 4 |
125 | acupoint-catgut-embedding | 3 |
126 | androgen-ablation | 3 |
127 | androgen-suppression | 3 |
128 | anti-aromatase | 3 |
129 | anti-hiv/aids | 3 |
130 | anti-interferon-gamma | 3 |
131 | anti-interleukin-13 | 3 |
132 | anti-interleukin-23 | 3 |
133 | anti-jev | 3 |
134 | anti-pcp | 3 |
135 | antiretrovial | 3 |
136 | artemisinin-combination | 3 |
137 | biomaterials/biological | 3 |
138 | cancer-targeted | 3 |
139 | capecitabine/cddp | 3 |
140 | combination/high-dose | 3 |
141 | doublet-targeted | 3 |
142 | elastocompressive | 3 |
143 | enzyme-inhibiting | 3 |
144 | fibrate-statin | 3 |
145 | fibrinogen-depleting | 3 |
146 | fluorinex | 3 |
147 | ifn-α/ribavirin | 3 |
148 | initial/maintenance | 3 |
149 | massage-exercise | 3 |
150 | mortality-reducing | 3 |
151 | non-dominated | 3 |
152 | omeprazole-based | 3 |
153 | platin-containing | 3 |
154 | quinidine-mexiletine | 3 |
155 | ribavirin-based | 3 |
156 | speed-feedback | 3 |
157 | temple-three-needle | 3 |
158 | thread-dragging | 3 |
159 | transfusion/chelation | 3 |
160 | uric-acid-lowering | 3 |
161 | wet-wrap | 3 |
162 | 'consistent | 2 |
163 | 'electroconvulsive | 2 |
164 | acupuncture/massage | 2 |
165 | anti-b-cell | 2 |
166 | anti-gal-3 | 2 |
167 | anti-interleukin-1α | 2 |
168 | anti-tslp | 2 |
169 | anti-wasting | 2 |
170 | antiarrhytmic | 2 |
171 | anticausal | 2 |
172 | antihypertensive-hypocholesterolaemic | 2 |
173 | antiinvasive | 2 |
174 | antiobiotic | 2 |
175 | antipain | 2 |
176 | asthma-controller | 2 |
177 | atg/g-csf | 2 |
178 | atomoxetine/fluoxetine | 2 |
179 | atp-tca-directed | 2 |
180 | behavioural/cognitive | 2 |
181 | beta-block | 2 |
182 | bevacizumb | 2 |
183 | bio-feedback | 2 |
184 | bio-logical | 2 |
185 | calcium-channel-blocker | 2 |
186 | complimentary/traditional | 2 |
187 | cp-containing | 2 |
188 | endobronchial-valve | 2 |
189 | endocrine-based | 2 |
190 | endocrine-modulating | 2 |
191 | fa-statin | 2 |
192 | fcap | 2 |
193 | fixed-duration | 2 |
194 | fluvastatin-fibrate | 2 |
195 | footzone | 2 |
196 | game+no | 2 |
197 | gefitinib-free | 2 |
198 | greater-than-starting-dose | 2 |
199 | her-2-targeted | 2 |
200 | hidac-based | 2 |
201 | hormonorestorative | 2 |
202 | hot-tub | 2 |
203 | hypertransfusion | 2 |
204 | icp/cpp-guided | 2 |
205 | igf-1r-targeted | 2 |
206 | immune-directed | 2 |
207 | intensive-phase | 2 |
208 | interferon-α-based | 2 |
209 | lactate-guided | 2 |
210 | least-active | 2 |
211 | met-targeted | 2 |
212 | microtubule-depolymerizing | 2 |
213 | miticidal | 2 |
214 | mmp-3-driven | 2 |
215 | modal-dose | 2 |
216 | myoregeneration | 2 |
217 | non-gemcitabine-based | 2 |
218 | non-guideline-adherent | 2 |
219 | non-raasi-based | 2 |
220 | nonbetalactam | 2 |
221 | nonparicalcitol | 2 |
222 | oestrogen-progestogen | 2 |
223 | orthotraction | 2 |
224 | platelet-directed | 2 |
225 | pre-sns | 2 |
226 | ranibizumab-based | 2 |
227 | reality-mediated | 2 |
228 | respondent-cognitive | 2 |
229 | sclerocompression | 2 |
230 | severity-appropriate | 2 |
231 | sof+rbv | 2 |
232 | statin-fna | 2 |
233 | thromboreductive | 2 |
234 | tubulin-targeting | 2 |
235 | tumour-targeted | 2 |
236 | vasotropic | 2 |
237 | vbloc® | 2 |
238 | vegf-selective | 2 |
239 | 'aqua | 1 |
240 | 'mime | 1 |
241 | 'pool | 1 |
242 | 'spa | 1 |
243 | 'uva | 1 |
244 | 'uvb | 1 |
245 | 1-antibiotic | 1 |
246 | 28-days-off | 1 |
247 | 5-nitroimidazol | 1 |
248 | acaricidial | 1 |
249 | acceptance-based-behavioral | 1 |
250 | acne+bleeding | 1 |
251 | acupressure-associated | 1 |
252 | acute/drug | 1 |
253 | adjunctive-medical | 1 |
254 | adrenoceptor-targeted | 1 |
255 | adv+lam | 1 |
256 | alfuzosin/finasteride | 1 |
257 | alk-targeted | 1 |
258 | aml-directed | 1 |
259 | amplipulse | 1 |
260 | anthracycline/docetaxel | 1 |
261 | anti-angiogenesis-targeted | 1 |
262 | anti-endocrine | 1 |
263 | anti-her-2-targeted | 1 |
264 | anti-impulse | 1 |
265 | anti-mediator | 1 |
266 | anti-oncological | 1 |
267 | anti-platelet/thrombotic | 1 |
268 | anti-polymerisation | 1 |
269 | anti-smoke | 1 |
270 | anti-thrombotic/anti-anginal | 1 |
271 | antiangiogenic-based | 1 |
272 | antiantiinflammatory | 1 |
273 | antibiotica | 1 |
274 | anticongestive | 1 |
275 | antidepressant/anxiolytic | 1 |
276 | antiembolic | 1 |
277 | antifungal/steroid | 1 |
278 | antihelminth | 1 |
279 | antimetaboilte | 1 |
280 | antimicrobial-only | 1 |
281 | antiplalelet | 1 |
282 | antiplatetet | 1 |
283 | antiplatlet | 1 |
284 | antipsychotic/benzodiazepine | 1 |
285 | antiretrovrial | 1 |
286 | antiretrroviral | 1 |
287 | antirretroviral | 1 |
288 | antithrombotic/anti-anginal | 1 |
289 | antithypertensive | 1 |
290 | aprepitant/fosaprepitant | 1 |
291 | aransep | 1 |
292 | articoagulant | 1 |
293 | asa-capsaicin | 1 |
294 | ascriptin | 1 |
295 | asd-related | 1 |
296 | atenolol/thiazide-based | 1 |
297 | atropine-alone | 1 |
298 | azathioprine-prednisone | 1 |
299 | b-lactam | 1 |
300 | bad-tolerated | 1 |
301 | baldless | 1 |
302 | benazapril-valsartan | 1 |
303 | benazeprilate-valsartan | 1 |
304 | better-optimized | 1 |
305 | bevacizumab-taxane | 1 |
306 | bezafibrate-colestyramine | 1 |
307 | bezafibrate/statin | 1 |
308 | bisphophonate | 1 |
309 | bisphosphonate-based | 1 |
310 | bmsc-based | 1 |
311 | breathing-adapted | 1 |
312 | bronchodilatort | 1 |
313 | c-radiation | 1 |
314 | caix-targeted | 1 |
315 | candesartan-plus-enalapril | 1 |
316 | carboplatin/paclitaxel-based | 1 |
317 | carvedilol/digoxin | 1 |
318 | cbt/other | 1 |
319 | cd20-depleting | 1 |
320 | cefotaxime/ceftriaxone | 1 |
321 | ceftriaxone-erythromycin | 1 |
322 | cerumeno-eblytic | 1 |
323 | cholecystographic | 1 |
324 | cholestyramine-neomycin | 1 |
325 | clofibrate-cholestyramine | 1 |
326 | cocorticosteroid | 1 |
327 | cognitive-based-behavioural | 1 |
328 | cognitive-coping | 1 |
329 | cognitive–behavioral | 1 |
330 | cognitive–behavioural | 1 |
331 | cogntive-behavioral | 1 |
332 | compassion-focused | 1 |
333 | contraction-inducing | 1 |
334 | conventionnal | 1 |
335 | copper-modulating | 1 |
336 | cortisonic | 1 |
337 | coxibe | 1 |
338 | daily-based | 1 |
339 | destiffening | 1 |
340 | dietary/nutritional | 1 |
341 | dmard-based | 1 |
342 | dolphin-assisted | 1 |
343 | dose-up-phase | 1 |
344 | double-modality | 1 |
345 | doxazosin/finasteride | 1 |
346 | dp-based | 1 |
347 | drug/physical | 1 |
348 | dual-control | 1 |
349 | dual-medication | 1 |
350 | education/sports | 1 |
351 | eighth-line | 1 |
352 | electro/thermal | 1 |
353 | estradiol-dydrogesterone | 1 |
354 | ethodolac | 1 |
355 | etiologically-guided | 1 |
356 | etiothropic | 1 |
357 | fdg-pet-adapted | 1 |
358 | fibrinolitic | 1 |
359 | first-/second-line | 1 |
360 | first-line-targeted | 1 |
361 | flebotonic | 1 |
362 | flow-diversion | 1 |
363 | fluid-guided | 1 |
364 | fluid/nutrition | 1 |
365 | forced-use | 1 |
366 | g-gsf | 1 |
367 | gc-ctl | 1 |
368 | gerosuppressant | 1 |
369 | goal-targeted | 1 |
370 | habit-modifying | 1 |
371 | half-attended | 1 |
372 | hormone-guided | 1 |
373 | hsp70-targeting | 1 |
374 | hydroclorothiazide | 1 |
375 | hygienic-phase | 1 |
376 | hyperosmolal | 1 |
377 | hypnobehavioral | 1 |
378 | hypnozoitocidal | 1 |
379 | icp/cpp-directed | 1 |
380 | ige-blocker | 1 |
381 | iib/iiia-inhibitor | 1 |
382 | ill-toxic | 1 |
383 | imidazoquinazoline | 1 |
384 | imipenem-ertapenem | 1 |
385 | imipenem-meropenem | 1 |
386 | immunogene | 1 |
387 | immunoplacental | 1 |
388 | immunspressive | 1 |
389 | induction-consolidation | 1 |
390 | insulin-plus-glucose | 1 |
391 | interferon-gamma-targeted | 1 |
392 | intervention/preventive | 1 |
393 | intolerance-of-uncertainty | 1 |
394 | iodine-31 | 1 |
395 | irinotecan-added | 1 |
396 | irinotecan-including | 1 |
397 | irinotecan/5-fu-based | 1 |
398 | iron-replacement | 1 |
399 | iv-combined | 1 |
400 | kca3.1-directed | 1 |
401 | l-thyroxine-suppressive | 1 |
402 | la-glp-1ra | 1 |
403 | laba/corticosteroid | 1 |
404 | leptin-replacement | 1 |
405 | levofloxacin-base | 1 |
406 | limb-directed | 1 |
407 | lipid-lowering/statin | 1 |
408 | lipid-modification | 1 |
409 | lisinopril-based | 1 |
410 | lithium-anticonvulsant | 1 |
411 | lithium-antipsychotic | 1 |
412 | lmwh-bridging | 1 |
413 | lon-gtermpravastatin | 1 |
414 | losar-tan | 1 |
415 | lovastatin-gemfibrozil | 1 |
416 | magnetolaser | 1 |
417 | manipulation-based | 1 |
418 | marital/couples/family | 1 |
419 | megavitamin | 1 |
420 | melphalan/corticosteroid | 1 |
421 | membrane-disruptive | 1 |
422 | mericitabine/placebo | 1 |
423 | metastases-directed | 1 |
424 | metformin-including | 1 |
425 | metformin/clomiphene | 1 |
426 | metoclopramide-based | 1 |
427 | migraine-abortive | 1 |
428 | mindbody | 1 |
429 | mini-pulse | 1 |
430 | miniheparin | 1 |
431 | mmf/tacrolimus | 1 |
432 | molecular-guided | 1 |
433 | mono-infusion | 1 |
434 | mono-rifampin | 1 |
435 | morning-time | 1 |
436 | mortality.urate-lowering | 1 |
437 | motivation-enhancement | 1 |
438 | mpi-based | 1 |
439 | multi-convergent | 1 |
440 | multi-drugs | 1 |
441 | multihormonal | 1 |
442 | multiple-dose/day | 1 |
443 | naproxen-amitriptyline | 1 |
444 | nb-uvb-alone | 1 |
445 | nbac | 1 |
446 | nbsi | 1 |
447 | neomycin-niacin | 1 |
448 | nikan | 1 |
449 | non-budesonide | 1 |
450 | non-egfr-targeted | 1 |
451 | non-guideline-oriented | 1 |
452 | non-rebamipide-containing | 1 |
453 | non-saat | 1 |
454 | non-vegfr-tki | 1 |
455 | nonmetronidazole | 1 |
456 | nonpsychostimulant | 1 |
457 | nonuseful | 1 |
458 | ntiplatelet | 1 |
459 | nucleos/tide-analogue | 1 |
460 | nutlin-based | 1 |
461 | nutraceutial | 1 |
462 | oestrogen-replacement | 1 |
463 | oestrogen/gestagen | 1 |
464 | osteoclast-targeted | 1 |
465 | osterosarcoma | 1 |
466 | outcomes.thrombolytic | 1 |
467 | oxaliplatin/fluoropyrimidine | 1 |
468 | pac-led | 1 |
469 | parent-child/family | 1 |
470 | paricalcitol-centered | 1 |
471 | pdt-hsp-inhibition | 1 |
472 | peg-ifnα-based | 1 |
473 | pegintrona | 1 |
474 | periodontitis.srp | 1 |
475 | ph-targeted | 1 |
476 | ph/us/swd | 1 |
477 | photo-dynamic | 1 |
478 | physical/body-mind | 1 |
479 | piogli- | 1 |
480 | placebo-preemptive | 1 |
481 | placebo/supportive | 1 |
482 | platelet-suppressant | 1 |
483 | platinum/cyclophosphamide | 1 |
484 | pomalidomide-based | 1 |
485 | post-concurrent | 1 |
486 | post-help | 1 |
487 | postpartum/drug | 1 |
488 | ppi/amoxicillin/clarithromycin | 1 |
489 | ppi/amoxicillin/metronidazole | 1 |
490 | pravastation | 1 |
491 | prednisone/azathioprine | 1 |
492 | prehospital-initiated | 1 |
493 | prfa+pei | 1 |
494 | psycho-dynamic | 1 |
495 | psychotherapy/behavioral | 1 |
496 | pth-replacement | 1 |
497 | purging-tonifying | 1 |
498 | ql-enhancing | 1 |
499 | quercetin/rf/doxorubicin | 1 |
500 | radioioine | 1 |
501 | radiometabolic | 1 |
502 | raloxifene-alone | 1 |
503 | referral.pharmacological | 1 |
504 | regimen.progestogen | 1 |
505 | regimens-losartan-based | 1 |
506 | relaxation/massage | 1 |
507 | relevancethe | 1 |
508 | reperfusion-directed | 1 |
509 | rhtsh-based | 1 |
510 | risk-targeted | 1 |
511 | ropinirole+physical | 1 |
512 | rules-an | 1 |
513 | safed | 1 |
514 | salt/heat | 1 |
515 | sdmard/biologic | 1 |
516 | sedentary-estrogen | 1 |
517 | selection/screening | 1 |
518 | sequential/alternating | 1 |
519 | signal-responsive | 1 |
520 | simvastatin/bezafibrate | 1 |
521 | single-acting | 1 |
522 | single-antiplatelet | 1 |
523 | single-pill-combination | 1 |
524 | sofosbuvir-containing | 1 |
525 | spasmolytics.bulking | 1 |
526 | splint-plus-hand | 1 |
527 | stage-appropriate | 1 |
528 | stasis-eliminating | 1 |
529 | statin-interferon | 1 |
530 | stavudine/didanosine-based | 1 |
531 | stent-change | 1 |
532 | steroid/bronchodilator | 1 |
533 | stimulation/harmonization | 1 |
534 | stratin | 1 |
535 | stromal-based | 1 |
536 | sulphomamide | 1 |
537 | sulpiride-olanzapine | 1 |
538 | sunscreening | 1 |
539 | syk-inhibition | 1 |
540 | symptomatically-oriented | 1 |
541 | systemic/systems-oriented | 1 |
542 | t4-suppressive | 1 |
543 | targeted-cancer | 1 |
544 | targeted-hcc | 1 |
545 | taxane/anthracycline | 1 |
546 | taylor-made | 1 |
547 | telaprevir-containing | 1 |
548 | thrombolysoangioplasty | 1 |
549 | tissue-selecting | 1 |
550 | tnf-α-blocking | 1 |
551 | tnfalpha-directed | 1 |
552 | tolazamide | 1 |
553 | treatment-an | 1 |
554 | treatment-arm-specific | 1 |
555 | treatment-maintenance | 1 |
556 | triple-antiplatelet | 1 |
557 | two-second-line | 1 |
558 | uroceptic | 1 |
559 | vacuum-seal | 1 |
560 | vasospasmolytic | 1 |
561 | vegf/vegfr-targeted | 1 |
562 | veraflo™ | 1 |
563 | viral-static | 1 |
564 | visuomotor-imagery | 1 |
565 | ~bullet~pharmacological | 1 |
566 | ß₂-agonist | 1 |
567 | â-blocker | 1 |
568 | α-blocker/5ari | 1 |
1 | 'aqua | 1 |
2 | 'consistent | 2 |
3 | 'electroconvulsive | 2 |
4 | 'mime | 1 |
5 | 'pool | 1 |
6 | 'spa | 1 |
7 | 'uva | 1 |
8 | 'uvb | 1 |
9 | 1-antibiotic | 1 |
10 | 28-days-off | 1 |
11 | 5-nitroimidazol | 1 |
12 | acaricidial | 1 |
13 | acceptance-based-behavioral | 1 |
14 | acne+bleeding | 1 |
15 | acupoint-catgut-embedding | 3 |
16 | acupoint-sticking | 4 |
17 | acupressure-associated | 1 |
18 | acupuncture/massage | 2 |
19 | acute/drug | 1 |
20 | adjunctive-medical | 1 |
21 | adpri | 14 |
22 | adrenoceptor-targeted | 1 |
23 | adv+lam | 1 |
24 | alfuzosin/finasteride | 1 |
25 | aliskiren-based | 14 |
26 | alk-targeted | 1 |
27 | aml-directed | 1 |
28 | amplipulse | 1 |
29 | androgen-ablation | 3 |
30 | androgen-deprivation | 57 |
31 | androgen-suppression | 3 |
32 | animal-assisted | 7 |
33 | anthracycline/docetaxel | 1 |
34 | anti-angiogenesis-targeted | 1 |
35 | anti-aromatase | 3 |
36 | anti-aβ | 18 |
37 | anti-b-cell | 2 |
38 | anti-coagulant | 16 |
39 | anti-ctla-4 | 27 |
40 | anti-cytokine | 12 |
41 | anti-diabetes | 24 |
42 | anti-egfr | 181 |
43 | anti-endocrine | 1 |
44 | anti-failure | 4 |
45 | anti-filarial | 9 |
46 | anti-gal-3 | 2 |
47 | anti-hcmv | 4 |
48 | anti-hcv | 156 |
49 | anti-her-2 | 6 |
50 | anti-her-2-targeted | 1 |
51 | anti-her2 | 122 |
52 | anti-hiv/aids | 3 |
53 | anti-hormonal | 12 |
54 | anti-ige | 116 |
55 | anti-il-1 | 6 |
56 | anti-il-12/23 | 12 |
57 | anti-il-13 | 12 |
58 | anti-impulse | 1 |
59 | anti-interferon-gamma | 3 |
60 | anti-interleukin-13 | 3 |
61 | anti-interleukin-1α | 2 |
62 | anti-interleukin-23 | 3 |
63 | anti-jev | 3 |
64 | anti-leukaemic | 7 |
65 | anti-leukotriene | 24 |
66 | anti-mediator | 1 |
67 | anti-oncological | 1 |
68 | anti-pcp | 3 |
69 | anti-pd-1 | 11 |
70 | anti-platelet | 200 |
71 | anti-platelet/thrombotic | 1 |
72 | anti-polymerisation | 1 |
73 | anti-proteus | 5 |
74 | anti-retroviral | 83 |
75 | anti-smoke | 1 |
76 | anti-t-cell | 4 |
77 | anti-thrombotic/anti-anginal | 1 |
78 | anti-tnf | 413 |
79 | anti-tnf-alpha | 58 |
80 | anti-tnf-α | 81 |
81 | anti-tnfalpha | 29 |
82 | anti-tnfα | 75 |
83 | anti-tslp | 2 |
84 | anti-tuberculous | 20 |
85 | anti-vegf | 244 |
86 | anti-wasting | 2 |
87 | antiangiogenic-based | 1 |
88 | antiantiinflammatory | 1 |
89 | antiarrhytmic | 2 |
90 | antibiotica | 1 |
91 | anticausal | 2 |
92 | anticholesterol | 9 |
93 | anticoagulant | 1,514 |
94 | anticongestive | 1 |
95 | anticytokine | 17 |
96 | antidepressant/anxiolytic | 1 |
97 | antiembolic | 1 |
98 | antifungal/steroid | 1 |
99 | antihelminth | 1 |
100 | antihypertensive-hypocholesterolaemic | 2 |
101 | antihypotensive | 8 |
102 | antiinvasive | 2 |
103 | antileukotriene | 8 |
104 | antilipid | 18 |
105 | antimetaboilte | 1 |
106 | antimicrobial-only | 1 |
107 | antiobiotic | 2 |
108 | antipain | 2 |
109 | antiplalelet | 1 |
110 | antiplatelet | 2,737 |
111 | antiplatelet/no | 4 |
112 | antiplatetet | 1 |
113 | antiplatlet | 1 |
114 | antipsychotic/benzodiazepine | 1 |
115 | antiretrovial | 3 |
116 | antiretroviral | 3,535 |
117 | antiretrovrial | 1 |
118 | antiretrroviral | 1 |
119 | antirretroviral | 1 |
120 | antithrombotic | 1,050 |
121 | antithrombotic/anti-anginal | 1 |
122 | antithypertensive | 1 |
123 | aprepitant/fosaprepitant | 1 |
124 | aransep | 1 |
125 | artemisinin-combination | 3 |
126 | articoagulant | 1 |
127 | asa-capsaicin | 1 |
128 | ascriptin | 1 |
129 | asd-related | 1 |
130 | aspirin-oac | 6 |
131 | asthma-controller | 2 |
132 | atenolol/thiazide-based | 1 |
133 | atg/g-csf | 2 |
134 | atomoxetine/fluoxetine | 2 |
135 | atp-tca-directed | 2 |
136 | atropine-alone | 1 |
137 | azathioprine-prednisone | 1 |
138 | b-lactam | 1 |
139 | bad-tolerated | 1 |
140 | baldless | 1 |
141 | behavioural/cognitive | 2 |
142 | benazapril-valsartan | 1 |
143 | benazeprilate-valsartan | 1 |
144 | beta-block | 2 |
145 | beta-lactam-based | 5 |
146 | better-optimized | 1 |
147 | bevacizumab-taxane | 1 |
148 | bevacizumb | 2 |
149 | bezafibrate-colestyramine | 1 |
150 | bezafibrate/statin | 1 |
151 | bian-stone | 4 |
152 | bio-feedback | 2 |
153 | bio-logical | 2 |
154 | biomaterials/biological | 3 |
155 | bioresonance | 7 |
156 | bisphophonate | 1 |
157 | bisphosphonate-based | 1 |
158 | bmsc-based | 1 |
159 | bone-modifying | 9 |
160 | bone-targeted | 37 |
161 | breathing-adapted | 1 |
162 | bronchodilatort | 1 |
163 | c-radiation | 1 |
164 | caix-targeted | 1 |
165 | calcium-channel-blocker | 2 |
166 | cancer-targeted | 3 |
167 | candesartan-plus-enalapril | 1 |
168 | capecitabine/cddp | 3 |
169 | carboplatin/paclitaxel-based | 1 |
170 | carvedilol/digoxin | 1 |
171 | cbt/other | 1 |
172 | cd20-depleting | 1 |
173 | cefotaxime/ceftriaxone | 1 |
174 | ceftriaxone-erythromycin | 1 |
175 | cerumeno-eblytic | 1 |
176 | chemo-endocrine | 13 |
177 | chemoendocrine | 20 |
178 | chemohormonal | 14 |
179 | chin-cup | 5 |
180 | cholecystographic | 1 |
181 | cholestyramine-neomycin | 1 |
182 | clofibrate-cholestyramine | 1 |
183 | cocorticosteroid | 1 |
184 | cognitive-based-behavioural | 1 |
185 | cognitive-behavior | 55 |
186 | cognitive-behaviour | 44 |
187 | cognitive-coping | 1 |
188 | cognitive–behavioral | 1 |
189 | cognitive–behavioural | 1 |
190 | cogntive-behavioral | 1 |
191 | coinitiation | 5 |
192 | combination/high-dose | 3 |
193 | compassion-focused | 1 |
194 | complimentary/traditional | 2 |
195 | contraction-inducing | 1 |
196 | conventionnal | 1 |
197 | copper-modulating | 1 |
198 | cortisonic | 1 |
199 | coxibe | 1 |
200 | cp-containing | 2 |
201 | cpp-targeted | 5 |
202 | cryo-tcm | 4 |
203 | cryoultrasound | 4 |
204 | cytokine-based | 6 |
205 | daily-based | 1 |
206 | dance/movement | 19 |
207 | destiffening | 1 |
208 | dietary/nutritional | 1 |
209 | dmard-based | 1 |
210 | dolphin-assisted | 1 |
211 | dose-up-phase | 1 |
212 | double-modality | 1 |
213 | doublet-targeted | 3 |
214 | doxazosin/finasteride | 1 |
215 | dp-based | 1 |
216 | drug/physical | 1 |
217 | dual-antiplatelet | 30 |
218 | dual-control | 1 |
219 | dual-medication | 1 |
220 | education/sports | 1 |
221 | egfr-targeted | 26 |
222 | egfr-targeting | 7 |
223 | eighth-line | 1 |
224 | elastocompressive | 3 |
225 | electro-convulsive | 5 |
226 | electro/thermal | 1 |
227 | electroconvulsive | 265 |
228 | electrophysical | 23 |
229 | endobronchial-valve | 2 |
230 | endocrine-based | 2 |
231 | endocrine-modulating | 2 |
232 | enzyme-inhibiting | 3 |
233 | enzyme-replacement | 4 |
234 | eryc | 4 |
235 | estradiol-dydrogesterone | 1 |
236 | estrogen-progestogen | 18 |
237 | estrogen-replacement | 4 |
238 | ethodolac | 1 |
239 | etiologically-guided | 1 |
240 | etiothropic | 1 |
241 | fa-statin | 2 |
242 | fcap | 2 |
243 | fdg-pet-adapted | 1 |
244 | fibrate-statin | 3 |
245 | fibrinogen-depleting | 3 |
246 | fibrinolitic | 1 |
247 | first-/second-line | 1 |
248 | first-line-targeted | 1 |
249 | fixed-duration | 2 |
250 | flebotonic | 1 |
251 | flow-diversion | 1 |
252 | fluid-guided | 1 |
253 | fluid/nutrition | 1 |
254 | fluorinex | 3 |
255 | fluvastatin-fibrate | 2 |
256 | footzone | 2 |
257 | forced-use | 1 |
258 | g-gsf | 1 |
259 | game+no | 2 |
260 | gc-ctl | 1 |
261 | gefitinib-free | 2 |
262 | gerosuppressant | 1 |
263 | glp-1-based | 12 |
264 | goal-targeted | 1 |
265 | greater-than-starting-dose | 2 |
266 | habit-modifying | 1 |
267 | half-attended | 1 |
268 | hdl-raising | 11 |
269 | her-2-directed | 4 |
270 | her-2-targeted | 2 |
271 | her2-directed | 6 |
272 | her2-targeted | 22 |
273 | hidac-based | 2 |
274 | hormone-guided | 1 |
275 | hormone-replacement | 31 |
276 | hormonorestorative | 2 |
277 | hot-tub | 2 |
278 | hsp70-targeting | 1 |
279 | hydroclorothiazide | 1 |
280 | hygienic-phase | 1 |
281 | hyperosmolal | 1 |
282 | hypertransfusion | 2 |
283 | hypnobehavioral | 1 |
284 | hypnosis/relaxation | 4 |
285 | hypnozoitocidal | 1 |
286 | icp/cpp-based | 4 |
287 | icp/cpp-directed | 1 |
288 | icp/cpp-guided | 2 |
289 | ifn-based | 12 |
290 | ifn-α-based | 6 |
291 | ifn-α/ribavirin | 3 |
292 | ige-blocker | 1 |
293 | igf-1r-targeted | 2 |
294 | iib/iiia-inhibitor | 1 |
295 | ill-toxic | 1 |
296 | imidazoquinazoline | 1 |
297 | imipenem-ertapenem | 1 |
298 | imipenem-meropenem | 1 |
299 | immune-directed | 2 |
300 | immunogene | 1 |
301 | immunoplacental | 1 |
302 | immunspressive | 1 |
303 | induction-consolidation | 1 |
304 | initial/maintenance | 3 |
305 | insulin-plus-glucose | 1 |
306 | intensive-phase | 2 |
307 | interferon-based | 49 |
308 | interferon-gamma-targeted | 1 |
309 | interferon-α-based | 2 |
310 | intervention/preventive | 1 |
311 | intolerance-of-uncertainty | 1 |
312 | iodine-31 | 1 |
313 | irinotecan-added | 1 |
314 | irinotecan-including | 1 |
315 | irinotecan/5-fu-based | 1 |
316 | iron-replacement | 1 |
317 | iv-combined | 1 |
318 | kca3.1-directed | 1 |
319 | l-thyroxine-suppressive | 1 |
320 | la-glp-1ra | 1 |
321 | laba/corticosteroid | 1 |
322 | lactate-guided | 2 |
323 | least-active | 2 |
324 | leptin-replacement | 1 |
325 | levodopa-sparing | 9 |
326 | levofloxacin-base | 1 |
327 | limb-directed | 1 |
328 | lipid-lowering/statin | 1 |
329 | lipid-modification | 1 |
330 | lisinopril-based | 1 |
331 | lithium-anticonvulsant | 1 |
332 | lithium-antipsychotic | 1 |
333 | lmwh-bridging | 1 |
334 | lon-gtermpravastatin | 1 |
335 | losar-tan | 1 |
336 | lovastatin-gemfibrozil | 1 |
337 | magnetolaser | 1 |
338 | manipulation-based | 1 |
339 | marital/couples/family | 1 |
340 | massage-exercise | 3 |
341 | medicamental | 10 |
342 | megavitamin | 1 |
343 | melphalan/corticosteroid | 1 |
344 | membrane-disruptive | 1 |
345 | mericitabine/placebo | 1 |
346 | met-targeted | 2 |
347 | metastases-directed | 1 |
348 | metformin-including | 1 |
349 | metformin/clomiphene | 1 |
350 | metoclopramide-based | 1 |
351 | microtubule-depolymerizing | 2 |
352 | migraine-abortive | 1 |
353 | mindbody | 1 |
354 | mini-pulse | 1 |
355 | miniheparin | 1 |
356 | miticidal | 2 |
357 | mmf/tacrolimus | 1 |
358 | mmp-3-driven | 2 |
359 | modal-dose | 2 |
360 | molecular-guided | 1 |
361 | molecularly-targeted | 5 |
362 | mono-infusion | 1 |
363 | mono-rifampin | 1 |
364 | morita | 27 |
365 | morning-time | 1 |
366 | mortality-reducing | 3 |
367 | mortality.urate-lowering | 1 |
368 | motivation-enhancement | 1 |
369 | mpi-based | 1 |
370 | mud-bath | 18 |
371 | multi-convergent | 1 |
372 | multi-drugs | 1 |
373 | multihormonal | 1 |
374 | multiple-dose/day | 1 |
375 | music-movement | 5 |
376 | myoregeneration | 2 |
377 | naproxen-amitriptyline | 1 |
378 | nb-uvb-alone | 1 |
379 | nbac | 1 |
380 | nbsi | 1 |
381 | neomycin-niacin | 1 |
382 | nicotine-replacement | 43 |
383 | nikan | 1 |
384 | non-budesonide | 1 |
385 | non-dominated | 3 |
386 | non-egfr-targeted | 1 |
387 | non-gemcitabine-based | 2 |
388 | non-guideline-adherent | 2 |
389 | non-guideline-oriented | 1 |
390 | non-raasi-based | 2 |
391 | non-rebamipide-containing | 1 |
392 | non-saat | 1 |
393 | non-vegfr-tki | 1 |
394 | nonbetalactam | 2 |
395 | nonmetronidazole | 1 |
396 | nonparicalcitol | 2 |
397 | nonpsychostimulant | 1 |
398 | nonsensitizer | 5 |
399 | nonuseful | 1 |
400 | novottf | 8 |
401 | ntiplatelet | 1 |
402 | nucleos/tide-analogue | 1 |
403 | nutlin-based | 1 |
404 | nutraceutial | 1 |
405 | oestrogen-progestogen | 2 |
406 | oestrogen-replacement | 1 |
407 | oestrogen/gestagen | 1 |
408 | omeprazole-based | 3 |
409 | orthotraction | 2 |
410 | osteoclast-targeted | 1 |
411 | osterosarcoma | 1 |
412 | outcomes.thrombolytic | 1 |
413 | oxaliplatin/fluoropyrimidine | 1 |
414 | pac-led | 1 |
415 | pah-specific | 19 |
416 | parent-child/family | 1 |
417 | paricalcitol-centered | 1 |
418 | paricalcitol-centred | 4 |
419 | pbto2-based | 6 |
420 | pdt-hsp-inhibition | 1 |
421 | peg-ifnα-based | 1 |
422 | pegintrona | 1 |
423 | periodontitis.srp | 1 |
424 | pet-adapted | 8 |
425 | ph-specific | 7 |
426 | ph-targeted | 1 |
427 | ph/us/swd | 1 |
428 | photo-dynamic | 1 |
429 | photodynamic | 524 |
430 | physical/body-mind | 1 |
431 | piogli- | 1 |
432 | placebo-preemptive | 1 |
433 | placebo/supportive | 1 |
434 | platelet-directed | 2 |
435 | platelet-suppressant | 1 |
436 | platin-containing | 3 |
437 | platinum/cyclophosphamide | 1 |
438 | pomalidomide-based | 1 |
439 | post-concurrent | 1 |
440 | post-help | 1 |
441 | postpartum/drug | 1 |
442 | ppi/amoxicillin/clarithromycin | 1 |
443 | ppi/amoxicillin/metronidazole | 1 |
444 | pravastation | 1 |
445 | pre-antiretroviral | 8 |
446 | pre-sns | 2 |
447 | prednisone/azathioprine | 1 |
448 | prehospital-initiated | 1 |
449 | preload-reduction | 4 |
450 | prfa+pei | 1 |
451 | prn-pde5i | 4 |
452 | probucol-colestipol | 5 |
453 | psycho-dynamic | 1 |
454 | psychotherapy/behavioral | 1 |
455 | pth-replacement | 1 |
456 | purging-tonifying | 1 |
457 | ql-enhancing | 1 |
458 | quercetin/rf/doxorubicin | 1 |
459 | quinidine-mexiletine | 3 |
460 | radioioine | 1 |
461 | radiometabolic | 1 |
462 | radiopeptide | 5 |
463 | raloxifene-alone | 1 |
464 | ramipril-based | 11 |
465 | ranibizumab-based | 2 |
466 | rdtb | 4 |
467 | reality-mediated | 2 |
468 | referral.pharmacological | 1 |
469 | regimen.progestogen | 1 |
470 | regimens-losartan-based | 1 |
471 | relaxation/massage | 1 |
472 | relevancethe | 1 |
473 | renal-replacement | 16 |
474 | reperfusion-directed | 1 |
475 | respondent-cognitive | 2 |
476 | rhtsh-based | 1 |
477 | ribavirin-based | 3 |
478 | risk-targeted | 1 |
479 | ropinirole+physical | 1 |
480 | rules-an | 1 |
481 | safed | 1 |
482 | salt/heat | 1 |
483 | sclerocompression | 2 |
484 | sdmard/biologic | 1 |
485 | sedentary-estrogen | 1 |
486 | selection/screening | 1 |
487 | self-manual | 4 |
488 | sequential/alternating | 1 |
489 | severity-appropriate | 2 |
490 | signal-responsive | 1 |
491 | simvastatin/bezafibrate | 1 |
492 | single-acting | 1 |
493 | single-antiplatelet | 1 |
494 | single-pill-combination | 1 |
495 | sof+rbv | 2 |
496 | sofosbuvir-based | 5 |
497 | sofosbuvir-containing | 1 |
498 | sox+bv | 4 |
499 | spasmolytics.bulking | 1 |
500 | speed-feedback | 3 |
501 | splint-plus-hand | 1 |
502 | stage-appropriate | 1 |
503 | stasis-eliminating | 1 |
504 | statin-fna | 2 |
505 | statin-interferon | 1 |
506 | statin/fibrate | 4 |
507 | stavudine/didanosine-based | 1 |
508 | stent-change | 1 |
509 | steroid/bronchodilator | 1 |
510 | stimulation/harmonization | 1 |
511 | stratin | 1 |
512 | stromal-based | 1 |
513 | su-jok | 4 |
514 | sulphomamide | 1 |
515 | sulpiride-olanzapine | 1 |
516 | sunscreening | 1 |
517 | syk-inhibition | 1 |
518 | symptomatically-oriented | 1 |
519 | systemic/systems-oriented | 1 |
520 | t4-suppressive | 1 |
521 | targeted-cancer | 1 |
522 | targeted-hcc | 1 |
523 | taxane/anthracycline | 1 |
524 | taylor-made | 1 |
525 | telaprevir-containing | 1 |
526 | temple-three-needle | 3 |
527 | thionamide | 9 |
528 | third-tier | 5 |
529 | thread-dragging | 3 |
530 | thrombolysoangioplasty | 1 |
531 | thrombolytic | 1,335 |
532 | thromboreductive | 2 |
533 | tissue-selecting | 1 |
534 | tnf-blocking | 12 |
535 | tnf-α-blocking | 1 |
536 | tnfalpha-directed | 1 |
537 | tolazamide | 1 |
538 | transfusion/chelation | 3 |
539 | treatment-an | 1 |
540 | treatment-arm-specific | 1 |
541 | treatment-maintenance | 1 |
542 | triple-antiplatelet | 1 |
543 | tsh-suppressive | 18 |
544 | tuberculostatic | 6 |
545 | tubulin-targeting | 2 |
546 | tumour-targeted | 2 |
547 | two-second-line | 1 |
548 | urate-lowering | 55 |
549 | uric-acid-lowering | 3 |
550 | uroceptic | 1 |
551 | vacuum-seal | 1 |
552 | vasospasmolytic | 1 |
553 | vasotropic | 2 |
554 | vbloc® | 2 |
555 | vegf-selective | 2 |
556 | vegf-targeted | 24 |
557 | vegf/vegfr-targeted | 1 |
558 | veraflo™ | 1 |
559 | viral-static | 1 |
560 | visuomotor-imagery | 1 |
561 | vitalstim | 7 |
562 | waon | 37 |
563 | wet-wrap | 3 |
564 | yin-nourishing | 7 |
565 | ~bullet~pharmacological | 1 |
566 | ß₂-agonist | 1 |
567 | â-blocker | 1 |
568 | α-blocker/5ari | 1 |
1 | piogli- | 1 |
2 | anti-pd-1 | 11 |
3 | anti-il-1 | 6 |
4 | iodine-31 | 1 |
5 | anti-her-2 | 6 |
6 | anti-her2 | 122 |
7 | anti-gal-3 | 2 |
8 | anti-il-13 | 12 |
9 | anti-interleukin-13 | 3 |
10 | anti-interleukin-23 | 3 |
11 | anti-il-12/23 | 12 |
12 | anti-ctla-4 | 27 |
13 | antibiotica | 1 |
14 | anti-tnf-alpha | 58 |
15 | anti-tnfalpha | 29 |
16 | anti-interferon-gamma | 3 |
17 | osterosarcoma | 1 |
18 | statin-fna | 2 |
19 | pegintrona | 1 |
20 | 'spa | 1 |
21 | la-glp-1ra | 1 |
22 | morita | 27 |
23 | 'aqua | 1 |
24 | 'uva | 1 |
25 | bevacizumb | 2 |
26 | rdtb | 4 |
27 | hot-tub | 2 |
28 | 'uvb | 1 |
29 | nbac | 1 |
30 | ethodolac | 1 |
31 | aspirin-oac | 6 |
32 | targeted-hcc | 1 |
33 | pah-specific | 19 |
34 | ph-specific | 7 |
35 | treatment-arm-specific | 1 |
36 | sdmard/biologic | 1 |
37 | cholecystographic | 1 |
38 | radiometabolic | 1 |
39 | antiembolic | 1 |
40 | psycho-dynamic | 1 |
41 | photo-dynamic | 1 |
42 | photodynamic | 524 |
43 | anti-leukaemic | 7 |
44 | antihypertensive-hypocholesterolaemic | 2 |
45 | antiarrhytmic | 2 |
46 | cortisonic | 1 |
47 | flebotonic | 1 |
48 | etiothropic | 1 |
49 | vasotropic | 2 |
50 | viral-static | 1 |
51 | tuberculostatic | 6 |
52 | fibrinolitic | 1 |
53 | anti-platelet/thrombotic | 1 |
54 | antithrombotic | 1,050 |
55 | lithium-antipsychotic | 1 |
56 | 1-antibiotic | 1 |
57 | antiobiotic | 2 |
58 | uroceptic | 1 |
59 | cerumeno-eblytic | 1 |
60 | thrombolytic | 1,335 |
61 | outcomes.thrombolytic | 1 |
62 | antidepressant/anxiolytic | 1 |
63 | vasospasmolytic | 1 |
64 | ill-toxic | 1 |
65 | eryc | 4 |
66 | irinotecan-added | 1 |
67 | fluid-guided | 1 |
68 | hormone-guided | 1 |
69 | lactate-guided | 2 |
70 | icp/cpp-guided | 2 |
71 | molecular-guided | 1 |
72 | etiologically-guided | 1 |
73 | half-attended | 1 |
74 | safed | 1 |
75 | pac-led | 1 |
76 | iv-combined | 1 |
77 | paricalcitol-centered | 1 |
78 | paricalcitol-centred | 4 |
79 | glp-1-based | 12 |
80 | pbto2-based | 6 |
81 | ranibizumab-based | 2 |
82 | hidac-based | 2 |
83 | antiangiogenic-based | 1 |
84 | bmsc-based | 1 |
85 | dmard-based | 1 |
86 | metoclopramide-based | 1 |
87 | pomalidomide-based | 1 |
88 | atenolol/thiazide-based | 1 |
89 | omeprazole-based | 3 |
90 | non-gemcitabine-based | 2 |
91 | cytokine-based | 6 |
92 | endocrine-based | 2 |
93 | stavudine/didanosine-based | 1 |
94 | bisphosphonate-based | 1 |
95 | rhtsh-based | 1 |
96 | mpi-based | 1 |
97 | non-raasi-based | 2 |
98 | stromal-based | 1 |
99 | carboplatin/paclitaxel-based | 1 |
100 | ramipril-based | 11 |
101 | lisinopril-based | 1 |
102 | beta-lactam-based | 5 |
103 | regimens-losartan-based | 1 |
104 | aliskiren-based | 14 |
105 | ifn-based | 12 |
106 | nutlin-based | 1 |
107 | ribavirin-based | 3 |
108 | manipulation-based | 1 |
109 | interferon-based | 49 |
110 | dp-based | 1 |
111 | icp/cpp-based | 4 |
112 | sofosbuvir-based | 5 |
113 | irinotecan/5-fu-based | 1 |
114 | daily-based | 1 |
115 | ifn-α-based | 6 |
116 | interferon-α-based | 2 |
117 | peg-ifnα-based | 1 |
118 | compassion-focused | 1 |
119 | acupressure-associated | 1 |
120 | reality-mediated | 2 |
121 | prehospital-initiated | 1 |
122 | asd-related | 1 |
123 | non-dominated | 3 |
124 | bad-tolerated | 1 |
125 | kca3.1-directed | 1 |
126 | her-2-directed | 4 |
127 | her2-directed | 6 |
128 | atp-tca-directed | 2 |
129 | tnfalpha-directed | 1 |
130 | limb-directed | 1 |
131 | immune-directed | 2 |
132 | aml-directed | 1 |
133 | reperfusion-directed | 1 |
134 | icp/cpp-directed | 1 |
135 | metastases-directed | 1 |
136 | platelet-directed | 2 |
137 | her-2-targeted | 2 |
138 | anti-her-2-targeted | 1 |
139 | her2-targeted | 22 |
140 | interferon-gamma-targeted | 1 |
141 | first-line-targeted | 1 |
142 | bone-targeted | 37 |
143 | vegf-targeted | 24 |
144 | ph-targeted | 1 |
145 | alk-targeted | 1 |
146 | risk-targeted | 1 |
147 | goal-targeted | 1 |
148 | cpp-targeted | 5 |
149 | igf-1r-targeted | 2 |
150 | cancer-targeted | 3 |
151 | egfr-targeted | 26 |
152 | non-egfr-targeted | 1 |
153 | vegf/vegfr-targeted | 1 |
154 | adrenoceptor-targeted | 1 |
155 | tumour-targeted | 2 |
156 | anti-angiogenesis-targeted | 1 |
157 | doublet-targeted | 3 |
158 | met-targeted | 2 |
159 | osteoclast-targeted | 1 |
160 | caix-targeted | 1 |
161 | molecularly-targeted | 5 |
162 | non-guideline-oriented | 1 |
163 | systemic/systems-oriented | 1 |
164 | symptomatically-oriented | 1 |
165 | breathing-adapted | 1 |
166 | pet-adapted | 8 |
167 | fdg-pet-adapted | 1 |
168 | animal-assisted | 7 |
169 | dolphin-assisted | 1 |
170 | better-optimized | 1 |
171 | antifungal/steroid | 1 |
172 | laba/corticosteroid | 1 |
173 | melphalan/corticosteroid | 1 |
174 | cocorticosteroid | 1 |
175 | antilipid | 18 |
176 | splint-plus-hand | 1 |
177 | physical/body-mind | 1 |
178 | cryoultrasound | 4 |
179 | ph/us/swd | 1 |
180 | coxibe | 1 |
181 | treatment-maintenance | 1 |
182 | initial/maintenance | 3 |
183 | bioresonance | 7 |
184 | taylor-made | 1 |
185 | platinum/cyclophosphamide | 1 |
186 | sulphomamide | 1 |
187 | thionamide | 9 |
188 | tolazamide | 1 |
189 | non-budesonide | 1 |
190 | doxazosin/finasteride | 1 |
191 | alfuzosin/finasteride | 1 |
192 | radiopeptide | 5 |
193 | hydroclorothiazide | 1 |
194 | gefitinib-free | 2 |
195 | acupuncture/massage | 2 |
196 | relaxation/massage | 1 |
197 | anti-ige | 116 |
198 | stent-change | 1 |
199 | relevancethe | 1 |
200 | anti-smoke | 1 |
201 | temple-three-needle | 3 |
202 | ppi/amoxicillin/metronidazole | 1 |
203 | nonmetronidazole | 1 |
204 | 'mime | 1 |
205 | morning-time | 1 |
206 | bevacizumab-taxane | 1 |
207 | immunogene | 1 |
208 | metformin/clomiphene | 1 |
209 | anti-leukotriene | 24 |
210 | antileukotriene | 8 |
211 | oxaliplatin/fluoropyrimidine | 1 |
212 | anti-cytokine | 12 |
213 | anticytokine | 17 |
214 | two-second-line | 1 |
215 | first-/second-line | 1 |
216 | eighth-line | 1 |
217 | taxane/anthracycline | 1 |
218 | imidazoquinazoline | 1 |
219 | naproxen-amitriptyline | 1 |
220 | bezafibrate-colestyramine | 1 |
221 | clofibrate-cholestyramine | 1 |
222 | radioioine | 1 |
223 | sulpiride-olanzapine | 1 |
224 | antipsychotic/benzodiazepine | 1 |
225 | anti-endocrine | 1 |
226 | chemo-endocrine | 13 |
227 | chemoendocrine | 20 |
228 | prednisone/azathioprine | 1 |
229 | quinidine-mexiletine | 3 |
230 | atomoxetine/fluoxetine | 2 |
231 | nb-uvb-alone | 1 |
232 | raloxifene-alone | 1 |
233 | atropine-alone | 1 |
234 | estradiol-dydrogesterone | 1 |
235 | azathioprine-prednisone | 1 |
236 | bian-stone | 4 |
237 | cefotaxime/ceftriaxone | 1 |
238 | footzone | 2 |
239 | anti-failure | 4 |
240 | levofloxacin-base | 1 |
241 | hygienic-phase | 1 |
242 | intensive-phase | 2 |
243 | dose-up-phase | 1 |
244 | anti-aromatase | 3 |
245 | massage-exercise | 3 |
246 | mini-pulse | 1 |
247 | amplipulse | 1 |
248 | anti-impulse | 1 |
249 | insulin-plus-glucose | 1 |
250 | greater-than-starting-dose | 2 |
251 | combination/high-dose | 3 |
252 | modal-dose | 2 |
253 | forced-use | 1 |
254 | stage-appropriate | 1 |
255 | severity-appropriate | 2 |
256 | bisphophonate | 1 |
257 | fluvastatin-fibrate | 2 |
258 | statin/fibrate | 4 |
259 | simvastatin/bezafibrate | 1 |
260 | antimetaboilte | 1 |
261 | nucleos/tide-analogue | 1 |
262 | antiinvasive | 2 |
263 | electro-convulsive | 5 |
264 | electroconvulsive | 265 |
265 | 'electroconvulsive | 2 |
266 | antihypotensive | 8 |
267 | antithypertensive | 1 |
268 | signal-responsive | 1 |
269 | elastocompressive | 3 |
270 | t4-suppressive | 1 |
271 | l-thyroxine-suppressive | 1 |
272 | tsh-suppressive | 18 |
273 | immunspressive | 1 |
274 | hormonorestorative | 2 |
275 | least-active | 2 |
276 | vegf-selective | 2 |
277 | thromboreductive | 2 |
278 | respondent-cognitive | 2 |
279 | behavioural/cognitive | 2 |
280 | intervention/preventive | 1 |
281 | placebo-preemptive | 1 |
282 | membrane-disruptive | 1 |
283 | migraine-abortive | 1 |
284 | placebo/supportive | 1 |
285 | anticongestive | 1 |
286 | endobronchial-valve | 2 |
287 | 28-days-off | 1 |
288 | anti-vegf | 244 |
289 | anti-tnf | 413 |
290 | atg/g-csf | 2 |
291 | g-gsf | 1 |
292 | novottf | 8 |
293 | ql-enhancing | 1 |
294 | mortality-reducing | 3 |
295 | contraction-inducing | 1 |
296 | acupoint-catgut-embedding | 3 |
297 | acne+bleeding | 1 |
298 | irinotecan-including | 1 |
299 | metformin-including | 1 |
300 | lmwh-bridging | 1 |
301 | thread-dragging | 3 |
302 | yin-nourishing | 7 |
303 | acupoint-sticking | 4 |
304 | tnf-blocking | 12 |
305 | tnf-α-blocking | 1 |
306 | spasmolytics.bulking | 1 |
307 | selection/screening | 1 |
308 | sunscreening | 1 |
309 | destiffening | 1 |
310 | non-rebamipide-containing | 1 |
311 | platin-containing | 3 |
312 | cp-containing | 2 |
313 | telaprevir-containing | 1 |
314 | sofosbuvir-containing | 1 |
315 | cognitive-coping | 1 |
316 | levodopa-sparing | 9 |
317 | uric-acid-lowering | 3 |
318 | urate-lowering | 55 |
319 | mortality.urate-lowering | 1 |
320 | hdl-raising | 11 |
321 | endocrine-modulating | 2 |
322 | copper-modulating | 1 |
323 | stasis-eliminating | 1 |
324 | sequential/alternating | 1 |
325 | single-acting | 1 |
326 | tissue-selecting | 1 |
327 | hsp70-targeting | 1 |
328 | tubulin-targeting | 2 |
329 | egfr-targeting | 7 |
330 | cd20-depleting | 1 |
331 | fibrinogen-depleting | 3 |
332 | enzyme-inhibiting | 3 |
333 | anti-wasting | 2 |
334 | bone-modifying | 9 |
335 | habit-modifying | 1 |
336 | purging-tonifying | 1 |
337 | microtubule-depolymerizing | 2 |
338 | acute/drug | 1 |
339 | postpartum/drug | 1 |
340 | mud-bath | 18 |
341 | antihelminth | 1 |
342 | prn-pde5i | 4 |
343 | prfa+pei | 1 |
344 | non-vegfr-tki | 1 |
345 | α-blocker/5ari | 1 |
346 | adpri | 14 |
347 | nbsi | 1 |
348 | speed-feedback | 3 |
349 | bio-feedback | 2 |
350 | beta-block | 2 |
351 | su-jok | 4 |
352 | adjunctive-medical | 1 |
353 | bio-logical | 2 |
354 | referral.pharmacological | 1 |
355 | ~bullet~pharmacological | 1 |
356 | anti-oncological | 1 |
357 | biomaterials/biological | 3 |
358 | ropinirole+physical | 1 |
359 | drug/physical | 1 |
360 | electrophysical | 23 |
361 | miticidal | 2 |
362 | hypnozoitocidal | 1 |
363 | vacuum-seal | 1 |
364 | acaricidial | 1 |
365 | anti-filarial | 9 |
366 | antiretrovrial | 1 |
367 | nutraceutial | 1 |
368 | antiretrovial | 3 |
369 | hyperosmolal | 1 |
370 | electro/thermal | 1 |
371 | anti-thrombotic/anti-anginal | 1 |
372 | antithrombotic/anti-anginal | 1 |
373 | conventionnal | 1 |
374 | complimentary/traditional | 2 |
375 | dietary/nutritional | 1 |
376 | anti-hormonal | 12 |
377 | multihormonal | 1 |
378 | chemohormonal | 14 |
379 | antiretrroviral | 1 |
380 | anti-retroviral | 83 |
381 | antiretroviral | 3,535 |
382 | pre-antiretroviral | 8 |
383 | antirretroviral | 1 |
384 | acceptance-based-behavioral | 1 |
385 | cogntive-behavioral | 1 |
386 | psychotherapy/behavioral | 1 |
387 | hypnobehavioral | 1 |
388 | cognitive–behavioral | 1 |
389 | cognitive-based-behavioural | 1 |
390 | cognitive–behavioural | 1 |
391 | anticausal | 2 |
392 | immunoplacental | 1 |
393 | medicamental | 10 |
394 | self-manual | 4 |
395 | anthracycline/docetaxel | 1 |
396 | candesartan-plus-enalapril | 1 |
397 | lovastatin-gemfibrozil | 1 |
398 | anti-b-cell | 2 |
399 | anti-t-cell | 4 |
400 | 'pool | 1 |
401 | probucol-colestipol | 5 |
402 | anticholesterol | 9 |
403 | dual-control | 1 |
404 | nonparicalcitol | 2 |
405 | 5-nitroimidazol | 1 |
406 | gc-ctl | 1 |
407 | nonuseful | 1 |
408 | adv+lam | 1 |
409 | b-lactam | 1 |
410 | nonbetalactam | 2 |
411 | cryo-tcm | 4 |
412 | imipenem-ertapenem | 1 |
413 | imipenem-meropenem | 1 |
414 | vitalstim | 7 |
415 | rules-an | 1 |
416 | treatment-an | 1 |
417 | nikan | 1 |
418 | losar-tan | 1 |
419 | benazeprilate-valsartan | 1 |
420 | benazapril-valsartan | 1 |
421 | oestrogen/gestagen | 1 |
422 | sedentary-estrogen | 1 |
423 | estrogen-progestogen | 18 |
424 | oestrogen-progestogen | 2 |
425 | regimen.progestogen | 1 |
426 | mmp-3-driven | 2 |
427 | antipain | 2 |
428 | neomycin-niacin | 1 |
429 | asa-capsaicin | 1 |
430 | quercetin/rf/doxorubicin | 1 |
431 | cholestyramine-neomycin | 1 |
432 | ppi/amoxicillin/clarithromycin | 1 |
433 | ceftriaxone-erythromycin | 1 |
434 | megavitamin | 1 |
435 | mono-rifampin | 1 |
436 | miniheparin | 1 |
437 | ifn-α/ribavirin | 3 |
438 | stratin | 1 |
439 | fa-statin | 2 |
440 | fibrate-statin | 3 |
441 | bezafibrate/statin | 1 |
442 | lipid-lowering/statin | 1 |
443 | lon-gtermpravastatin | 1 |
444 | ascriptin | 1 |
445 | carvedilol/digoxin | 1 |
446 | waon | 37 |
447 | flow-diversion | 1 |
448 | sclerocompression | 2 |
449 | androgen-suppression | 3 |
450 | mono-infusion | 1 |
451 | hypertransfusion | 2 |
452 | dual-medication | 1 |
453 | lipid-modification | 1 |
454 | induction-consolidation | 1 |
455 | c-radiation | 1 |
456 | coinitiation | 5 |
457 | androgen-ablation | 3 |
458 | transfusion/chelation | 3 |
459 | single-pill-combination | 1 |
460 | artemisinin-combination | 3 |
461 | myoregeneration | 2 |
462 | fixed-duration | 2 |
463 | anti-polymerisation | 1 |
464 | pravastation | 1 |
465 | androgen-deprivation | 57 |
466 | hypnosis/relaxation | 4 |
467 | stimulation/harmonization | 1 |
468 | orthotraction | 2 |
469 | preload-reduction | 4 |
470 | syk-inhibition | 1 |
471 | pdt-hsp-inhibition | 1 |
472 | fluid/nutrition | 1 |
473 | statin-interferon | 1 |
474 | mericitabine/placebo | 1 |
475 | game+no | 2 |
476 | antiplatelet/no | 4 |
477 | fcap | 2 |
478 | wet-wrap | 3 |
479 | anti-pcp | 3 |
480 | capecitabine/cddp | 3 |
481 | aransep | 1 |
482 | post-help | 1 |
483 | anti-tslp | 2 |
484 | periodontitis.srp | 1 |
485 | chin-cup | 5 |
486 | targeted-cancer | 1 |
487 | cbt/other | 1 |
488 | third-tier | 5 |
489 | ige-blocker | 1 |
490 | calcium-channel-blocker | 2 |
491 | â-blocker | 1 |
492 | asthma-controller | 2 |
493 | magnetolaser | 1 |
494 | nonsensitizer | 5 |
495 | anti-egfr | 181 |
496 | cognitive-behavior | 55 |
497 | anti-mediator | 1 |
498 | steroid/bronchodilator | 1 |
499 | iib/iiia-inhibitor | 1 |
500 | cognitive-behaviour | 44 |
501 | anti-hiv/aids | 3 |
502 | anti-diabetes | 24 |
503 | multi-drugs | 1 |
504 | pre-sns | 2 |
505 | baldless | 1 |
506 | education/sports | 1 |
507 | anti-proteus | 5 |
508 | mmf/tacrolimus | 1 |
509 | anti-tuberculous | 20 |
510 | non-saat | 1 |
511 | salt/heat | 1 |
512 | antiplalelet | 1 |
513 | anti-platelet | 200 |
514 | ntiplatelet | 1 |
515 | antiplatelet | 2,737 |
516 | single-antiplatelet | 1 |
517 | triple-antiplatelet | 1 |
518 | dual-antiplatelet | 30 |
519 | antiplatlet | 1 |
520 | antiplatetet | 1 |
521 | anti-coagulant | 16 |
522 | anticoagulant | 1,514 |
523 | articoagulant | 1 |
524 | nonpsychostimulant | 1 |
525 | lithium-anticonvulsant | 1 |
526 | platelet-suppressant | 1 |
527 | gerosuppressant | 1 |
528 | aprepitant/fosaprepitant | 1 |
529 | multi-convergent | 1 |
530 | enzyme-replacement | 4 |
531 | nicotine-replacement | 43 |
532 | hormone-replacement | 31 |
533 | pth-replacement | 1 |
534 | renal-replacement | 16 |
535 | estrogen-replacement | 4 |
536 | oestrogen-replacement | 1 |
537 | leptin-replacement | 1 |
538 | iron-replacement | 1 |
539 | motivation-enhancement | 1 |
540 | music-movement | 5 |
541 | dance/movement | 19 |
542 | non-guideline-adherent | 2 |
543 | post-concurrent | 1 |
544 | 'consistent | 2 |
545 | bronchodilatort | 1 |
546 | ß₂-agonist | 1 |
547 | sox+bv | 4 |
548 | sof+rbv | 2 |
549 | anti-hcv | 156 |
550 | anti-jev | 3 |
551 | anti-hcmv | 4 |
552 | fluorinex | 3 |
553 | multiple-dose/day | 1 |
554 | mindbody | 1 |
555 | parent-child/family | 1 |
556 | marital/couples/family | 1 |
557 | antimicrobial-only | 1 |
558 | visuomotor-imagery | 1 |
559 | antiantiinflammatory | 1 |
560 | double-modality | 1 |
561 | intolerance-of-uncertainty | 1 |
562 | thrombolysoangioplasty | 1 |
563 | veraflo™ | 1 |
564 | vbloc® | 2 |
565 | anti-tnf-α | 81 |
566 | anti-interleukin-1α | 2 |
567 | anti-tnfα | 75 |
568 | anti-aβ | 18 |